Cerave Developed with Dermatologists Acne Control Cleanser

Description

The product, identified by SPL code 34089-3, is a topical cleanser formulated for the treatment of acne. It contains active ingredients specifically designed to combat acne through their efficacy against the condition. The formulation includes various chemical compounds that contribute to its therapeutic action. The product is available in a defined volume and concentration, ensuring appropriate dosing for effective use. Inactive ingredients such as water, glycerin, and additional components are included to enhance the formulation's stability and overall effectiveness.

Uses and Indications

This drug is indicated for the treatment of acne vulgaris. It effectively clears acne blemishes and promotes skin healing. Additionally, it aids in the prevention of new acne blemishes from forming.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The recommended dosage for the product is to apply it twice daily. Prior to application, the container should be shaken well. The user should wet their face and then work the product into a lather. It is important to massage the lather onto the face while avoiding contact with the eyes. After massaging, the product should be rinsed off thoroughly.

Contraindications

There are no specific contraindications listed for this product. However, it is advised that if the product is swallowed, immediate medical assistance should be sought or contact with a Poison Control Center should be made.

Warnings and Precautions

For external use only. This product is intended solely for topical application and should not be ingested.

Skin irritation and dryness may occur, particularly if this product is used concurrently with other topical acne medications. To minimize the risk of irritation, it is recommended that only one topical acne medication be used at a time. Healthcare professionals should advise patients to monitor their skin condition and discontinue use if significant irritation develops.

In the event of accidental ingestion, it is imperative to seek emergency medical assistance or contact a Poison Control Center immediately. Prompt action is essential to ensure patient safety.

Side Effects

Patients should be advised that the product is for external use only. This warning is critical to ensure safe and appropriate use, as improper application may lead to adverse effects not specified in the labeling. No additional adverse reactions have been reported in clinical trials or postmarketing experiences.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate this risk, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of one of the medications should be considered to alleviate symptoms. Monitoring for signs of skin irritation is recommended when initiating or adjusting treatment regimens involving topical acne therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Cerave Developed with Dermatologists Acne Control Cleanser (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

The product has not been specifically studied in pregnant patients, and there are no explicit warnings or precautions regarding its use during pregnancy. As such, the potential risks to fetal outcomes remain unclear. Healthcare professionals should consider the lack of data when prescribing this product to women of childbearing potential and weigh the benefits against any potential risks. It is advisable to monitor pregnant patients closely if the product is deemed necessary for use during pregnancy.

Lactation

There are no specific warnings or considerations regarding nursing mothers or lactation mentioned in the provided text. Therefore, healthcare professionals may consider the use of this medication in lactating mothers without specific contraindications. Further monitoring of breastfed infants may be warranted, although no specific effects on nursing infants have been documented.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include monitoring vital signs, providing symptomatic treatment, and ensuring the patient's safety.

If available, consultation with a poison control center or a medical toxicologist is recommended to guide further management and treatment options.

Documentation of the incident, including the substance involved, the amount taken, and the time of ingestion, is crucial for effective management and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question. Further studies may be necessary to elucidate these aspects of nonclinical toxicology.

Postmarketing Experience

No postmarketing experience details are available in the provided data.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the medication is swallowed. It is crucial for patients to understand the potential risks associated with accidental ingestion.

Additionally, healthcare providers should inform patients about the likelihood of skin irritation and dryness when using this medication concurrently with other topical acne treatments. Patients should be counseled to use only one topical acne medication at a time to minimize the risk of irritation. This guidance will help ensure safe and effective use of the medication while reducing the potential for adverse skin reactions.

Storage and Handling

The product is supplied in a container that must be stored at room temperature. It is essential to protect the product from light exposure to maintain its integrity. The container should be kept tightly closed when not in use to prevent contamination and degradation. Additionally, the product should be discarded after opening to ensure safety and efficacy.

Additional Clinical Information

The medication is administered topically and is recommended for use twice daily. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Cerave Developed with Dermatologists Acne Control Cleanser, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)